BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32150343)

  • 1. Detection of Small-Molecule Aggregation with High-Throughput Microplate Biophysical Methods.
    Allen SJ; Dower CM; Liu AX; Lumb KJ
    Curr Protoc Chem Biol; 2020 Mar; 12(1):e78. PubMed ID: 32150343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of Biophysics in High-Throughput Screening Hit Validation.
    Genick CC; Barlier D; Monna D; Brunner R; Bé C; Scheufler C; Ottl J
    J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility at the molecular level: development of a critical aggregation concentration (CAC) assay for estimating compound monomer solubility.
    Wang J; Matayoshi E
    Pharm Res; 2012 Jul; 29(7):1745-54. PubMed ID: 22422319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment screening using X-ray crystallography.
    Davies TG; Tickle IJ
    Top Curr Chem; 2012; 317():33-59. PubMed ID: 21678136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic approaches to small-molecule discovery in chemical biology.
    Wagner BK; Dey M
    Cell Chem Biol; 2021 Mar; 28(3):245. PubMed ID: 33740431
    [No Abstract]   [Full Text] [Related]  

  • 6. Open access high throughput drug discovery in the public domain: a Mount Everest in the making.
    Roy A; McDonald PR; Sittampalam S; Chaguturu R
    Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing Compound Reactivity and Aggregation Assay Interferences: Case Studies of Biochemical High-Throughput Screening Campaigns Benefiting from the National Institutes of Health
    Coussens NP; Auld DS; Thielman JR; Wagner BK; Dahlin JL
    SLAS Discov; 2021 Dec; 26(10):1280-1290. PubMed ID: 34218710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent hitters: nuisance artifacts in high-throughput screening.
    Yang ZY; He JH; Lu AP; Hou TJ; Cao DS
    Drug Discov Today; 2020 Apr; 25(4):657-667. PubMed ID: 31987936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: high-throughput affinity-based technologies for small-molecule drug discovery.
    Zhu Z; Cuozzo J
    J Biomol Screen; 2009 Dec; 14(10):1157-64. PubMed ID: 19822881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening.
    Paricharak S; Méndez-Lucio O; Chavan Ravindranath A; Bender A; IJzerman AP; van Westen GJP
    Brief Bioinform; 2018 Mar; 19(2):277-285. PubMed ID: 27789427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The European Lead Factory: An updated HTS compound library for innovative drug discovery.
    van Vlijmen H; Ortholand JY; Li VM; de Vlieger JSB
    Drug Discov Today; 2021 Oct; 26(10):2406-2413. PubMed ID: 33892142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-phase biological assays for drug discovery.
    Forsberg EM; Sicard C; Brennan JD
    Annu Rev Anal Chem (Palo Alto Calif); 2014; 7():337-59. PubMed ID: 25000820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-stoichiometric inhibition in integrated lead finding - a literature review.
    Klumpp M
    Expert Opin Drug Discov; 2016; 11(2):149-62. PubMed ID: 26653534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Learning from our mistakes: the 'unknown knowns' in fragment screening.
    Davis BJ; Erlanson DA
    Bioorg Med Chem Lett; 2013 May; 23(10):2844-52. PubMed ID: 23562240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resonant waveguide grating based assays for colloidal aggregate detection and promiscuity characterization in natural products.
    Wang R; Wang J; Liu Y; Zhang X; Liang X
    RSC Adv; 2019 Nov; 9(65):38055-38064. PubMed ID: 35541809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Guide to Run Affinity Screens Using Differential Scanning Fluorimetry and Surface Plasmon Resonance Assays.
    Bergsdorf C; Wright SK
    Methods Enzymol; 2018; 610():135-165. PubMed ID: 30390797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Throughput Differential Scanning Fluorimetry (DSF) Formulation Screening with Complementary Dyes to Assess Protein Unfolding and Aggregation in Presence of Surfactants.
    McClure SM; Ahl PL; Blue JT
    Pharm Res; 2018 Mar; 35(4):81. PubMed ID: 29508082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalent hits and where to find them.
    Lucas SCC; Blackwell JH; Hewitt SH; Semple H; Whitehurst BC; Xu H
    SLAS Discov; 2024 Apr; 29(3):100142. PubMed ID: 38278484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns.
    Rothenaigner I; Hadian K
    SLAS Discov; 2021 Aug; 26(7):851-854. PubMed ID: 33882754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.